StonvexLoading…
StonvexStonvexStonvexCore line items from ARVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2018 2018-12-31 |
|---|---|---|---|---|
Revenue | $46.70M | $21.80M | $18.30M | $14.30M |
Operating Income | $-188.40M | $-120.80M | $-51.50M | $-43.80M |
Net Income | $-191.00M | $-119.30M | $-70.30M | $-41.48M |
EPS (Diluted) | $-3.82 | $-3.02 | $-2.13 | Not available |
Total Assets | $1.58B | $717.40M | $301.64M | $199.28M |
Total Liabilities | $799.90M | $75.20M | $74.96M | $62.61M |
Cash & Equivalents | $108.30M | $588.40M | $9.21M | $3.19M |
Free Cash Flow OCF − CapEx | $554.70M | $-96.10M | $-46.90M | $-18.95M |
Shares Outstanding | 53.00M | 48.50M | 38.46M | 31.24M |